Monoaminergic activity in subregions of Raphé nuclei elicited by prior stress and the neuropeptide corticotropin-releasing factor

Journal of Neuroendocrinology

Volumn 15, Issue 12, 2003, Pages 1122-1133

  Summers, Cliff H ^a   Kampshoff, J L ^a   Ronan, P J ^a,b   Lowry, C A ^c   Prestbo, A A ^a   Korzan, W J ^a   Renner, K J ^a  

^a UNIVERSITY OF SOUTH DAKOTA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

CRF; Dopamine; Norepinephrine; Raph ; Restraint; Serotonin; Stress

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; CORTICOTROPIN RELEASING FACTOR; MONOAMINE; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; BRAIN STEM; CAGE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISSECTION; DORSAL RAPHE NUCLEUS; ELECTROCHEMICAL ANALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMOBILIZATION STRESS; MALE; MEDIAN RAPHE NUCLEUS; MESENCEPHALON; MONOAMINERGIC SYSTEM; NONHUMAN; PONS; PRIORITY JOURNAL; RAT; SEROTONINERGIC SYSTEM; TISSUE LEVEL;

5-HYDROXYTRYPTOPHAN; ANIMALS; CORTICOTROPIN-RELEASING HORMONE; HYDROXYINDOLEACETIC ACID; MALE; NOREPINEPHRINE; RAPHE NUCLEI; RATS; RATS, SPRAGUE-DAWLEY; RESTRAINT, PHYSICAL; SEROTONIN; STRESS;

EID: 0346752248     PISSN: 09538194     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2826.2003.01108.x     Document Type: Article

References (65)

1. Lowry CA. Functional subsets of serotonergic neurones: implications for control of the hypothalamic-pituitary-adrenal axis. J Neuroendocrinol 2002; 14: 911-923.
2. Dahlstrom A, Fuxe K. Localization of monoamines in the lower brain stem. Experientia 1964; 20: 398-399.
3. Steinbusch HW. Serotonin-immunoreactive neurons and their projections in the CNS. In: Björklund A, Hökfelt T, eds. Classical Transmitters and Transmitter Receptors in the CNS. Amsterdam: Elsevier, 1984, 68-125.
4. Sakai K, Crochet S. Differentiation of presumed serotonergic dorsal raphe neurons in relation to behavior and wake-sleep states. Neuroscience 2001; 104: 1141-1155.
5. Jacobs BL, Fornal CA. Activity of serotonergic neurons in behaving animals. Neuropsychopharmacology 1999; 21: 9S-15S.
6. Hammack SE, Richey KJ, Schmid MJ, LoPresti ML, Watkins LR, Maier SF. The role of corticotropin-releasing hormone in the dorsal raphe nucleus in mediating the behavioral consequences of uncontrollable stress. J Neurosci 2002; 22: 1020-1026.
7. Vale W, Spiess J, Rivier C, Rivier J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science 1981; 213: 1394-1397.
8. Herman JP, Cullinan WE. Neurocircuitry of stress. Central control of the hypothalamo-pituitary- adrenocortical axis. Trends Neurosci 1997; 20: 78-84.
9. Hsu DT, Chen FL, Takahashi LK, Kalin NH. Rapid stress-induced elevations in corticotropin-releasing hormone mRNA in rat central amygdala nucleus and hypothalamic paraventricular nucleus: an in situ hybridization analysis. Brain Res 1998; 788: 305-310.
10. Merchenthaler I. Corticotropin releasing factor (CRF)-like immunoreactivity in the rat central nervous system. Extrahypothalamic distribution. Peptides 1984; 5 (Suppl. 1): 53-69.
11. Ronan PJ, Lowry CA, Johnson PL, Renner KJ, Summers CH. Stress + CRF inhibit 5-HT in central amygdala. Soc Neurosci Abstract 1999; 25: 74.
12. Prestbo AA, Ronan PJ, Lowry CA, Renner KJ, Summers CH. Synergism CRF + AVP inhibit 5-HT in Ce amygdala. Soc Neurosci Abstract 1999; 25: 74.
13. Behan DP, Khongsaly O, Ling N, De Souza EB. Urocortin interaction with corticotropin-releasing factor (CRF) binding protein (CRF-BP): a novel mechanism for elevating 'free' CRF levels in human brain. Brain Res 1996; 725: 263-267.
14. Curtis AL, Lechner SM, Pavcovich LA, Valentino RJ. Activation of the locus coeruleus noradrenergic system by intracoerulear microinfusion of corticotropin-releasing factor: effects on discharge rate, cortical norepinephrine levels and cortical electroencephalographic activity. J Pharmacol Exp Ther 1997; 281: 163-172.
15. Dunn AJ, Berridge CW. Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses? Brain Res Rev 1990; 15: 71-100.
16. Potter E, Behan DP, Linton EA, Lowry PJ, Sawchenko PE, Vale WW. The central distribution of a corticotropin-releasing factor (CRF)-binding protein predicts multiple sites and modes of interaction with CRF. Proc Natl Acad Sci USA 1992; 89: 4192-4196.
17. Hauger RL, Grigoriadis DE, Dallman MF, Plotsky PM, Vale WW, Dautzenberg FM. International Union of Pharmacology. XXXVI. Current status of the nomenclature for receptors for corticotropin-releasing factor and their ligands. Pharmacol Rev 2003; 55: 21-26.
18. Bittencourt JC, Sawchenko PE. Do centrally administered neuropeptides access cognate receptors?: an analysis in the central corticotropin-releasing factor system. J Neurosci 2000; 20: 1142-1156.
19. Price ML, Curtis AL, Kirby LG, Valentino RJ, Lucki I. Effects of corticotropin-releasing factor on brain serotonergic activity. Neuropsychopharmacology 1998; 18: 492-502.
20. Kirby LG, Rice KC, Valentino RJ. Effects of corticotropin-releasing factor on neuronal activity in the serotonergic dorsal raphe nucleus. Neuropsychopharmacology 2000; 22: 148-162.
21. Lowry CA, Rodda JE, Lightman SL, Ingram CD. Corticotropin-releasing factor increases in vitro firing rates of serotonergic neurons in the rat dorsal raphe nucleus: evidence for activation of a topographically organized mesolimbocortical serotonergic system. J Neurosci 2000; 20: 7728-7736.
22. Kirby LG, Pernar L, Valentino RJ, Beck SG. Distinguishing characteristics of serotonin and non-serotonin-containing cells in the dorsal raphe nucleus: electrophysiological and immunohistochemical studies. Neuroscience 2003; 116: 669-683.
23. Valentino RJ, Liouterman L, Van Bockstaele EJ. Evidence for regional heterogeneity in corticotropin-releasing factor interactions in the dorsal raphe nucleus. J Comp Neurol 2001; 435: 450-463.
24. 1 receptor mRNA expression. J Neurosci 1995; 15: 6340-6350.
25. Chalmers DT, Lovenberg TW, Grigoriadis DE, Behan DP, De Souza EB. Corticotrophin-releasing factor receptors: from molecular biology to drug design. Trends Pharmacol Sci 1996; 17: 166-172.
26. Paxinos G, Watson C, Pennisi M, Topple A. Bregma, lambda and the interaural midpoint in stereotaxic surgery with rats of different sex, strain and weight. J Neurosci Meth 1985; 13: 139-143.
27. Glavin GB, Paré WP, Sandbak T, Bakke H-K, Murison R. Restraint stress in biomedical research: an update. Neurosci Biobehav Rev 1993; 18: 223-249.
28. Paré WP, Glavin GB. Restraint stress in biomedical research: a review. Neurosci Biobehav Rev 1986; 10: 339-370.
29. Palkovits M, Brownstein MJ. Maps and Guide to Microdissection of the Rat Brain. New York: Elsevier, 1988.
30. Renner KJ, Luine V. Analysis of temporal and dose-dependent effects of estrogen on monoamines in brain nuclei. Brain Res 1986; 366: 64-71.
31. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254.
32. Dinan TG. Serotonin: current understanding and the way forward. Int Clin Psychopharmacol 1996; 11 (Suppl. 1): 19-21.
33. Korzan WJ, Summers TR, Ronan PJ, Renner KJ, Summers CH. The role of monoaminergic nuclei during aggression and sympathetic social signaling. Brain Behav Evol 2001; 57: 317-327.
34. Morgan WW, Rudeen PK, Pfeil KA. Effect of immobilization stress on serotonin content and turnover in regions of the rat brain. Life Sci 1975; 17: 143-150.
35. Hotta M, Shibasaki T, Arai K, Demura H. Corticotropin-releasing factor receptor type 1 mediates emotional stress-induced inhibition of food intake and behavioral changes in rats. Brain Res 1999; 823: 221-225.
36. Givalois L, Arancibia S, Tapia-Arancibia L. Concomitant changes in CRH mRNA levels in rat hippocampus and hypothalamus following immobilization stress. Brain Res Mol Brain Res 2000; 75: 166-171.
37. Abe K, Hiroshige T. Changes in plasma corticosterone and hypothalamic CRF levels following intraventricular injection or drug-induced changes of brain biogenic amines in the rat. Neuroendocrinology 1974; 14: 195-211.
38. 2A receptors. Pharmacol Biochem Behav 1998; 61: 405-412.
39. Mitchell SN, Thomas PJ. Effect of restraint stress and anxiolytics on 5-HT turnover in rat brain. Pharmacology 1988; 37: 105-113.
40. Summers CH. Mechanisms for quick and variable responses. Brain Behav Evol 2001; 57: 283-292.
41. Summers CH. Social interaction over time, implications for stress responsiveness. Integ Comp Biol 2002; 42: 591-599.
42. Winberg S, Lepage O. Elevation of brain 5-HT activity, POMC expression, and plasma cortisol in socially subordinate rainbow trout. Am J Physiol 1998; 274: R645-R654.
43. Le AD, Harding S, Juzytsch W, Fletcher PJ, Shaham Y. The role of corticotropin-releasing factor in the median raphe nucleus in relapse to alcohol. J Neurosci 2002; 22: 7844-7849.
44. Chamas F, Serova L, Sabban EL. Tryptophan hydroxylase mRNA levels are elevated by repeated immobilization stress in rat raphe nuclei but not in pineal gland. Neurosci Lett 1999; 267: 157-160.
45. Chamas F, Sabban EL. Role of the 5′ untranslated region (UTR) in the tissue-specific regulation of rat tryptophan hydroxylase gene expression by stress. J Neurochem 2002; 82: 645-654.
46. McBlane JW, Handley SL. Effects of two stressors on behaviour in the elevated X-maze: preliminary investigation of their interaction with 8-OH-DPAT. Psychopharmacol (Berl) 1994; 116: 173-182.
47. Graeff FG, Guimaraes FS, De Andrade TG, Deakin JF. Role of 5-HT in stress, anxiety and depression. Pharmacol Biochem Behav 1996; 54: 129-141.
48. Chung KK, Martinez M, Herbert J. c-fos expression, behavioural, endocrine and autonomic responses to acute social stress in male rats after chronic restraint: modulation by serotonin. Neuroscience 2000; 95: 453-463.
49. 1A autoreceptor sensitivity in the rat dorsal raphe nucleus - in vitro electrophysiological evidence. Fundam Clin Pharmacol 1997; 11: 206-214.
50. Laaris N, Le Poul E, Laporte AM, Hamon M, Lanfumey L. Differential effects of stress on presynaptic and postsynaptic 5-hydroxytryptamine-1A receptors in the rat brain: an in vitro electrophysiological study. Neuroscience 1999; 91: 947-958.
51. Greenwood BN, Foley TE, Day HE, Campisi J, Hammack SH, Campeau S, Maier SF, Fleshner M. Freewheel running prevents learned helplessness/behavioral depression: role of dorsal raphe serotonergic neurons. J Neurosci 2003; 23: 2889-2898.
52. Pich EM, Lorang M, Yeganeh M, Rodriguez DF, Raber J, Koob GF, Weiss F. Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis. J Neurosci 1995; 15: 5439-5447.
53. Van Loon GR, Shum A, Ho D. Lack of effect of corticotropin releasing factor on hypothalamic dopamine and serotonin synthesis turnover rates in rats. Peptides 1982; 3: 799-803.
54. Shannon NJ, Gunnet JW, Moore KE. A comparison of biochemical indices of 5-hydroxytryptaminergic neuronal activity following electrical stimulation of the dorsal raphe nucleus. J Neurochem 1986; 47: 958-965.
55. Korzan WJ, Prestbo AA, Ronan PJ, Renner KJ, Summers CH. Amygdalar monoaminergic activity is influenced by CRF and stress. Soc Neurosci Abstract 2000; 26: 2266.
56. Korzan WJ, Prestbo AA, Ronan PJ, Renner KJ, Summers CH. Monoaminergic activity in hypothalamus is influenced by stress and icv CRF. Soc Neurosci Abstract 2001; 27: 414.5.
57. Linthorst AC, Flachskamm C, Hopkins SJ, Hoadley ME, Labeur MS, Holsboer F, Reul JM. Long-term intracerebroventricular infusion of corticotropin-releasing hormone alters neuroendocrine, neurochemical, autonomic, behavioral, and cytokine responses to a systemic inflammatory challenge. J Neurosci 1997; 17: 4448-4460.
58. Summers CH, Prestbo AA, Ronan PJ, Korzan WJ, Renner KJ. Hippocampal monoaminergic activity is influenced regionally by stress and CRF. Soc Neurosci Abstract 2001; 27: 176.12.
59. Linthorst AC, Penalva RG, Flachskamm C, Holsboer F, Reul JM. Forced swim stress activates rat hippocampal serotonergic neurotransmission involving a corticotropin-releasing hormone receptor-dependent mechanism. Eur J Neurosci 2002; 16: 2441-2452.
60. Dunn AJ. Stress-related activation of cerebral dopaminergic systems. Ann NY Acad Sci 1988; 537: 188-205.
61. Gervais J, Rouillard C. Dorsal raphe stimulation differentially modulates dopaminergic neurons in the ventral tegmental area and substantia nigra. Synapse 2000; 35: 281-291.
62. 2 receptor-mediated regulation of serotonin extracellular concentration in the dorsal raphe nucleus of freely moving rats. J Neurochem 1993; 61: 772-775.
63. Ferre S, Cortes R, Artigas F. Dopaminergic regulation of the serotonergic raphe-striatal pathway: microdialysis studies in freely moving rats. J Neurosci 1994; 14: 4839-4846.
64. 4 receptor involvement in the serotonin-enhanced dopamine efflux from the substantia nigra of the freely moving rat: a microdialysis study. Brain Res 1998; 796: 117-124.
65. Page ME, Abercrombie ED. Discrete local application of corticotropin-releasing factor increases locus coeruleus discharge and extracellular norepinephrine in rat hippocampus. Synapse 1999; 33: 304-313.